Alex Knapp, Forbes Staff

Author's posts

Prime Movers Lab Raises A $500 Million Early Growth Fund To Invest In Breakthrough Science

The new fund will be focused on startups in energy, manufacturing, agriculture, healthcare, satellites and more.

InnovationRx: A 31,000-Year-Old Surgery; Plus: Feds May Stop Covid Support

InnovationRx is your weekly digest of healthcare news. Sign up!

InnovationRx: FDA Greenlights Omicron Boosters; Plus: Biotech’s Cash Cushion

InnovationRx is your weekly digest of healthcare news. Sign up!

Pfizer And BioNTech Ask FDA To Authorize Omicron Covid Booster

On Monday, Pfizer and BioNTech announced they have asked the FDA to grant an emergency use authorization for their new version of a Covid-19 vaccine that’s been adapted to be specific to the BA.4/BA.5 versions of the Omicron variant.

InnovationRx: Stretching Monkeypox Vaccine Doses; Plus, Omicron Subvariant Boosters

InnovationRx is your weekly digest of healthcare news. Sign up!

InnovationRx: WHO Declares Monkeypox Emergency; Plus: Covid’s Animal Origins

InnovationRx is your weekly digest of healthcare news. Sign up!

InnovationRx: General Catalyst’s New Healthcare Fund; Plus: Covid Boosts Diabetes Risk

InnovationRx is your weekly digest of healthcare news. Sign up!

Butterfly Network Inks Deal To Provide Portable Ultrasound Devices To Medical University Of South Carolina

The company’s devices will be used in clinical and research settings first before being introduced to the medical school.

InnovationRx: Cerebral Stops ADHD Prescribing; Plus, Big Sales For Covid Vaccines

InnovationRx is your weekly digest of healthcare news. Sign up!

Novavax Claims Positive Results From Early Trials Of Combination Covid/Flu Vaccine

The company will be moving into more clinical trials for the vaccine through 2022 and 2023.